10.3 Ventricular Function & MUGA Scans

10.3 Ventricular Function & MUGA Scans

Quick Answer: MUGA scans accurately measure the Left Ventricular Ejection Fraction (LVEF) by imaging a patient's own Tc-99m labeled red blood cells. The process relies on ECG R-wave gating to sync the images with the cardiac cycle. It is heavily utilized to monitor heart function during cardiotoxic chemotherapy.

Radionuclide Ventriculography (RVG), most commonly referred to as a Multigated Acquisition (MUGA) scan or Equilibrium Radionuclide Angiocardiography (ERNA), is a highly accurate and reproducible method for evaluating the pumping function of the heart, specifically the ventricles.

Radiopharmaceuticals: Red Blood Cell Labeling

To visualize the blood pool within the heart chambers, the patient's own red blood cells (RBCs) must be labeled with Technetium-99m. This requires preparing the RBCs with Stannous (Tin) Pyrophosphate (Sn-PYP). The stannous ion reduces the Tc-99m pertechnetate, allowing it to bind securely to the beta chain of the hemoglobin molecule inside the RBC.

There are three primary methods for labeling RBCs:

1. In Vivo Method: Stannous pyrophosphate is injected directly into the patient. After 15-30 minutes, Tc-99m pertechnetate is injected. Labeling occurs within the patient's bloodstream. This method has the lowest labeling efficiency (60-80%), resulting in higher background soft tissue activity.
2. Modified In Vivo Method: Stannous pyrophosphate is injected into the patient. Blood is then drawn into a syringe containing the Tc-99m pertechnetate. The syringe is incubated for ~10 minutes, and the labeled blood is reinjected. Labeling efficiency is better (85-90%).
3. Modified In Vitro Method (e.g., UltraTag kit): Blood is drawn from the patient and added to a reaction vial containing stannous ion and other reagents. After a series of steps involving sodium hypochlorite and ACD solution, Tc-99m pertechnetate is added to the vial. The entire labeling process occurs outside the body. This provides the highest labeling efficiency (>95%) and the sharpest images, making it the preferred method in modern practice.

Image Acquisition: ECG Gating

To evaluate the mechanical function of the beating heart, the gamma camera must synchronize its image acquisition with the patient's cardiac cycle. This is achieved using ECG Gating.

• The R-wave of the electrocardiogram is used as the trigger point because it represents the onset of ventricular depolarization (and subsequent contraction/systole).
• The cardiac cycle (the R-to-R interval) is divided into multiple frames or "gates" (typically 16 to 32 frames per cycle).
• As the heart beats, counts acquired during the first fraction of a second after the R-wave are stored in Frame 1. Counts from the next fraction are stored in Frame 2, and so on. This process is repeated over hundreds of heartbeats. The computer then sums the data to create an aggregated, cinematic loop of a single, representative cardiac cycle.

Data Analysis and LVEF Calculation

The most important quantitative measurement derived from a MUGA scan is the Left Ventricular Ejection Fraction (LVEF). This represents the percentage of blood pumped out of the left ventricle with each contraction.

To calculate LVEF, regions of interest (ROIs) are drawn over the left ventricle at its fullest point (End-Diastole) and its emptiest point (End-Systole). A background ROI is also drawn adjacent to the heart to account for scatter and overlying tissue activity.

• EDC (End-Diastolic Counts): Counts in the LV at maximum volume.
• ESC (End-Systolic Counts): Counts in the LV at minimum volume.
• BKG (Background Counts): Activity in the background ROI.

The LVEF Formula:

LVEF = [(EDC - BKG) - (ESC - BKG)] / (EDC - BKG) * 100

Simplified mathematically, this is:

LVEF = (EDC - ESC) / (EDC - BKG) * 100

Note: A normal LVEF is typically considered to be 50% or higher. Values below 50% indicate impaired left ventricular systolic function.

Regional Wall Motion

In addition to calculating the global LVEF, the physician visually assesses the cinematic display to evaluate regional wall motion. The walls of the ventricle should contract uniformly inward (normokinesis). Abnormalities include:

• Hypokinesis: Reduced contraction.
• Akinesis: No contraction.
• Dyskinesis: Paradoxical outward bulging during systole (often indicative of a ventricular aneurysm from a prior massive infarct).

Clinical Indication: Cardiotoxicity Monitoring

While echocardiograms (ultrasound) are also used to assess LVEF, MUGA scans are considered the "gold standard" for reproducibility. Because the calculation is based on radioactive counts (which are directly proportional to volume) rather than geometric assumptions, it is highly accurate even if the ventricle is distorted.

Therefore, MUGA scans are the preferred modality for serial monitoring of patients receiving cardiotoxic chemotherapy, most notably anthracyclines like doxorubicin (Adriamycin). These drugs can cause dose-dependent, irreversible heart failure. Patients undergo a baseline MUGA scan before starting treatment, and subsequent scans before each cycle of the drug. If the LVEF drops significantly (e.g., an absolute drop of 10-15% or a drop below the normal threshold of 50%), the oncologist may alter or halt the chemotherapy regimen to prevent permanent cardiac damage.